期刊文献+

催化信号扩增法检测人巨细胞病毒被膜磷蛋白65的实验分析

Evaluation of catalyzed signal amplification in detecting human cytomegalovirus phosphoprotein 65
原文传递
导出
摘要 目的建立一种新型的快速诊断肾移植受者人巨细胞病毒(HCMV)活动性感染的方法。方法采用免疫组织化学催化信号扩增法,通过抗HCMV被膜磷蛋白65(pp65)单克隆抗体AAC10对外周血WBC中的HCMV pp65抗原进行标记识别。并与荧光定量PCR(FQ-PCR)方法进行比较。结果检测的102例肾移植受者中,血浆HCMV DNA阳性66例,HCMV pp65抗原阳性56例,血浆HCMV DNA阴性患者中无pp65阳性,两种方法检测的符合率为90.2%,相关性好(r= 0.831);HCMV病患者31例,两者均阳性;同时检测40名健康者,结果pp65抗原全为阴性。结论催化信号扩增法敏感、简便,能更准确地反映HCMV感染的活动状况,有助于肾移植术后HCMV病的早期诊断,并可指导抗病毒治疗。 Objective To establish a new method for rapid diagnosis of the active human cyto- megalovirus(HCMV) infection in renal transplant recipients. Methods HCMV phosphoprotein(pp) 65 antigen in peripheral blood leucocytes was detected by immunohistochemistry method and catalyzed signal amplification with HCMV monochonal antibody AAC10, and the results were compared with those of fluorescent quantitative polymerase chain reaction(FQ-PCR) assay. Results Of 102 renal transplant recipients, 66 were positive for HCMV DNA in plasma. Among them, 56 were positive for pp65. No patients whose HCMV DNA levels in plasma was negative were pp65 positive. The coincidence of two assays was 90. 2%, with high relationship(r = 0. 831). Both HCMV DNA and pp65 were positive in 31 cases of HCMV infection. And HCMV pp65 was all negative in 40 healthy controls. Conclusions Catalyzed signal amplification is sensitive, convenient and reliable in the diagnosis of HCMV infection. This method is effective in early diagnosis of HCMV infection in renal transplant recipients and is helpful for the antiviral treatment.
出处 《中华传染病杂志》 CAS CSCD 北大核心 2007年第10期624-627,共4页 Chinese Journal of Infectious Diseases
关键词 巨细胞病毒 免疫组织化学 聚合酶链反应 催化作用 Cytomegalovirus Immunohistochemistry Polymerase chain reaction Catalysis
  • 相关文献

参考文献11

  • 1Kim DH, Won DI, Lee NY, et al. Survival benefit of asymptomatic cytomegalovirus reactivation after HLA-identical allogeneic peripheral blood stem cell transplantation. Transplantation, 2006, 81:101-108.
  • 2邱红玉.人巨细胞病毒pp65的基础及应用研究[J].国外医学(妇幼保健分册),2003,14(2):92-94. 被引量:8
  • 3王陶然.即刻早期和晚期基因的转录产物在巨细胞病毒感染中的诊断作用[J].国外医学(病毒学分册),2003,10(1):22-25. 被引量:6
  • 4Sanno N, Teramoto A, Sugiyama M, et al. Application of catalyzed signal amplification in immunodetection of gonadotropin subunits in clinically nonfunctioning pituitary adenomas. Am J Clin Pathol, 1996, 106:16-21.
  • 5Hokeberg I, Landqvist M, Grillner L. Detection of eytomegalovirus directly in blood leucocytes and evaluation of a new monoclonal antibody, AAC10. Serodiagnosis Immunotherapy Infect Dis, 1990, 4:419-426.
  • 6Singh N, Paterson DL, Gayowski T, et al. Cytomegalovirus antigenemia direeted pre-emptive prophylaxis with oral versus I.V. ganeielovir for the prevention of eytomegalovirus disease in liver transplant reeipients: a randomized, eontrolled trial. Transplantation, 2000, 70:717-722.
  • 7sThe TH, van den Berg AP, van Son WJ, et al. Monitoring for eytomegalovirus after organ transplantation: a clinical perspeetive. Transplant Proe, 1993, 25(5 Suppl 4) : 5-9.
  • 8Greijer AE, Adriaanse HM, Dekkers CA, et al. Multiplex real-time NASBA for monitoring expression dynamics of human cytomegalovirus encoded IEl and pp67 RNA. J Clin Virol, 2002, 24:57-66.
  • 9覃海燕,盛瑞媛,张月秋.巨细胞病毒pp65抗原血症检测[J].中华传染病杂志,2002,20(4):215-217. 被引量:25
  • 10Villa M, Lage E, Ballesteros S, et al. Preemptive therapy for the prevention of cytomegalovirus disease following heart transplantation directed by PP65 antigenemia. Transplant Proc, 2003, 35:732-734.

二级参考文献37

  • 1[1]Gaytant MA, Steegers EA, Semmekrot BA, et al. Congenital cytomegalovirus infection: review of the epidemiology and outcome [ J ]. Obstet Gynecol Surv,2002,57(4) :245 - 256.
  • 2[2]Bankier AT, Beck S, Bohni R, et al. The DNA sequence of the human cytomegalovirus genome [J].DNA Seq, 1991,2(1): 1 - 12.
  • 3[3]Hensel G, Meyer H, Gartner S, et al. Nuclear location of human cytomegalovirus tegument protein pp150 (ppUL32) [J]. J Gen Virol, 1995,76:1591 - 1601.
  • 4[4]Dal MP, Bessia C, Ripalti A, et al. Stabley expressed antisense RNA to cytomegalovirus UL 83 inhibits viral replication[J]. J Virol, 1996,70(4) :2086 - 2094.
  • 5[5]Schmolke S, Kern H, Drescher P, et al. The dominant phosphoprotein pp65 (UL 83) of huamn cytomegalovirus is dispensable for growth in cell culture[J]. J Gen Virol, 1995,69 (10): 5959 - 5968.
  • 6[6]Vaz SJ, Lule J, Rohrlich P, et al. Ex vivo stimulation and expansion of both CD4 ( + ) and CD8 ( + ) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65 [ J ]. J Virol, 2001,75 (17): 7840 - 7847.
  • 7[7]Wills MR, Carmichael A, Mynard K, et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structureal protein pp65:frequency, specificity, and T-cell receptor usage of pp65-specific CTL[J]. J Virol, 1996, 70 ( 11 ): 7569 -7579.
  • 8[8]Gyulai Z, Endresz V, Burian K, et al. Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, ppl50, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs[J]. J Infect Dis,2000,181 (5): 1537 - 1546.
  • 9[9]Diamond DJ, York J, Sun JY, et al. Development of a candidate HLA A 0201 restricted peptide-based vaccine against human cytomegalovirus infection [ J ]. Blood,1997,90:1751 - 1767.
  • 10[10]Beninga J, Kropff B, Mach M, et al. Comparative analysis of fourteen individual HCMV proteins for helper T cell response[ J ]. J Gen Virol, 1995,76 (pt. 1 ):153 - 160.

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部